See more : Keikyu Corporation (9006.T) Income Statement Analysis – Financial Results
Complete financial analysis of NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NorthWest Healthcare Properties Real Estate Investment Trust, a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- Arvind Fashions Limited (ARVINDFASN.NS) Income Statement Analysis – Financial Results
- Gequity S.p.A. (GEQ.MI) Income Statement Analysis – Financial Results
- Abhinav Leasing and Finance Limited (ALFL.BO) Income Statement Analysis – Financial Results
- Totoku Electric Co., Ltd. (5807.T) Income Statement Analysis – Financial Results
- Hera S.p.A. (HRASF) Income Statement Analysis – Financial Results
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF)
About NorthWest Healthcare Properties Real Estate Investment Trust
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at September 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 190 income-producing properties and 15.4 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand. The REIT's portfolio of medical office buildings, clinics, and hospitals is characterized by long term indexed leases and stable occupancies. With a fully integrated and aligned senior management team, the REIT leverages over 200 professionals across nine offices in 5 countries to serve as a long-term real estate partner to leading healthcare operators.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 522.68M | 448.83M | 374.61M | 373.82M | 366.06M | 349.59M | 313.97M | 277.35M | 198.96M | 150.43M | 150.11M | 134.46M | 118.15M | 64.97M |
| Cost of Revenue | 121.37M | 100.48M | 68.55M | 76.36M | 75.92M | 79.59M | 74.18M | 72.65M | 53.00M | 69.64M | 68.59M | 60.83M | 53.68M | 18.77M |
| Gross Profit | 401.30M | 348.35M | 306.07M | 297.46M | 290.13M | 270.00M | 239.78M | 204.70M | 145.96M | 80.79M | 81.52M | 73.63M | 64.48M | 46.20M |
| Gross Profit Ratio | 76.78% | 77.61% | 81.70% | 79.57% | 79.26% | 77.23% | 76.37% | 73.81% | 73.36% | 53.71% | 54.31% | 54.76% | 54.57% | 71.11% |
| Research & Development | 0.00 | 3.43M | 9.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 57.57M | 47.87M | 40.20M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 7.83M | 7.28M | 1.69M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.76K | 71.25K | 0.00 | 0.00 |
| SG&A | 57.57M | 47.87M | 40.20M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 7.83M | 7.29M | 1.77M | 3.22M | 1.82M |
| Other Expenses | 0.00 | -15.22M | -10.35M | 81.65M | -46.99M | 35.50M | -24.02M | -25.58M | 514.00K | 8.76M | 15.38M | -7.54M | 40.42M | 0.00 |
| Operating Expenses | 46.75M | 36.08M | 39.29M | 29.44M | 34.08M | 27.11M | 25.13M | 19.77M | 25.12M | 8.76M | 15.38M | -7.54M | 3.22M | 31.36M |
| Cost & Expenses | 168.13M | 136.55M | 107.84M | 105.80M | 110.00M | 106.70M | 99.31M | 92.42M | 78.12M | 69.64M | 68.59M | 60.83M | 56.90M | 50.13M |
| Interest Income | 46.50M | 9.18M | 4.60M | 1.95M | 6.44M | 11.24M | 4.55M | 2.85M | 912.00K | 834.00K | 816.00K | 2.00M | 97.58K | 0.00 |
| Interest Expense | 233.85M | 163.88M | 102.17M | 103.33M | 130.81M | 143.40M | 105.44M | 85.90M | 78.00M | 31.60M | 31.25M | 28.42M | 23.43M | 13.79M |
| Depreciation & Amortization | 1.27M | 1.40M | 1.38M | 1.58M | 1.98M | 1.30M | 1.41M | 750.00K | 275.00K | 1.56M | 1.56M | -1.25M | 0.00 | 20.27M |
| EBITDA | 355.82M | 353.69M | 377.56M | 393.93M | 146.64M | 283.29M | 215.49M | 144.07M | 116.94M | 77.71M | 24.57M | 58.42M | 61.25M | 35.63M |
| EBITDA Ratio | 68.08% | 80.17% | 95.67% | 105.38% | 40.06% | 81.04% | 68.64% | 51.95% | 58.78% | 51.66% | 56.76% | 43.44% | 51.84% | 54.83% |
| Operating Income | 354.55M | 358.42M | 357.01M | 392.35M | 144.65M | 281.99M | 214.08M | 143.32M | 116.67M | 77.71M | 85.20M | 58.42M | 61.25M | 15.36M |
| Operating Income Ratio | 67.83% | 79.86% | 95.30% | 104.96% | 39.52% | 80.66% | 68.19% | 51.68% | 58.64% | 51.66% | 56.76% | 43.44% | 51.84% | 23.64% |
| Total Other Income/Expenses | -853.58M | -153.02M | 364.20M | -147.91M | 16.83M | -41.43M | 99.76M | -1.41M | 147.06M | -49.55M | -45.00M | 18.86M | 40.42M | 0.00 |
| Income Before Tax | -499.03M | 204.92M | 736.07M | 396.24M | 161.48M | 201.46M | 276.42M | 183.52M | 259.95M | -22.20M | 36.52M | 92.49M | 101.67M | 0.00 |
| Income Before Tax Ratio | -95.47% | 45.66% | 196.49% | 106.00% | 44.11% | 57.63% | 88.04% | 66.17% | 130.65% | -14.75% | 24.33% | 68.79% | 86.05% | 0.00% |
| Income Tax Expense | -18.29M | 79.30M | 124.23M | 14.82M | 88.23M | 72.72M | 51.18M | 54.38M | 42.52M | 11.54M | 12.19M | 180.79K | 23.33M | 14.31M |
| Net Income | -347.69M | 125.63M | 611.84M | 314.36M | 73.25M | 65.72M | 67.39M | 56.96M | 116.85M | -22.20M | 36.52M | 92.49M | 78.34M | 1.05M |
| Net Income Ratio | -66.52% | 27.99% | 163.33% | 84.09% | 20.01% | 18.80% | 21.46% | 20.54% | 58.73% | -14.75% | 24.33% | 68.79% | 66.31% | 1.62% |
| EPS | -1.46 | 0.53 | 2.73 | 1.79 | 0.48 | 0.63 | 0.67 | 0.82 | 2.22 | -0.57 | 0.94 | 2.40 | 2.22 | 0.04 |
| EPS Diluted | -1.46 | 0.52 | 2.73 | 1.79 | 0.48 | 0.63 | 0.67 | 0.82 | 2.22 | -0.57 | 0.94 | 2.40 | 2.22 | 0.04 |
| Weighted Avg Shares Out | 243.29M | 237.32M | 224.13M | 175.98M | 153.63M | 103.57M | 101.04M | 69.44M | 52.69M | 39.12M | 38.78M | 38.50M | 35.23M | 28.16M |
| Weighted Avg Shares Out (Dil) | 243.29M | 240.65M | 224.13M | 175.98M | 153.63M | 103.57M | 101.04M | 69.44M | 52.69M | 39.12M | 38.78M | 38.50M | 35.23M | 28.17M |
NorthWest Healthcare REIT: JVs, Debt Reduction And An Upgrade
We had switched from a bearish view after Q3-2022 results. The stock has cooperated and dropped 27% since. We tell you why we are giving this an upgrade.
NorthWest Healthcare Properties REIT: High Dividend In Deep Value Territory
NorthWest Healthcare Properties REIT stock experienced a significant decline of 40% over the past year as rates rose and short-term liquidity problems emerged. Their ~10% yield is not covered by operations, jeopardizing their 2 decade long history of paying the...
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) Q1 2023 Earnings Call Transcript
NorthWest Healthcare Properties Real Estate Investment Trust (OTC:NWHUF) Q1 2023 Results Conference Call May 12, 2023 10:00 AM ET Company Participants Paul Lana - Chairman, CEO Shailen Chande - CFO Conference Call Participants Tal Woolley - National Bank Financial Pammi...
NorthWest Healthcare: How To Play The Upcoming Distribution Cut
We gave NorthWest Healthcare a Sell rating the last time around and the stock has dutifully moved lower. The glaring red flags on the dividend have only become a brighter shade of crimson since then.
NorthWest Healthcare: A Risky REIT With An 8.2% Yield
NorthWest Healthcare has a stable portfolio with high occupancy rates of 97% with the majority of leases indexed to inflation. However, rising interest rates have put pressure on REIT's balance sheet and eroded AFFO growth.
NorthWest Healthcare: Q3-2022 Shows Trouble Is Brewing
NorthWest Healthcare reported Q3-2022 results and updated on a few key initiatives. Adjusted funds from operations dropped sharply and dividend payout ratio hit 133%.
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) Q3 2022 Earnings Call Transcript
NorthWest Healthcare Properties Real Estate Investment Trust (OTC:NWHUF) Q3 2022 Earnings Conference Call November 15, 2022 10:00 AM ET Company Participants Paul Lana - Chairman & CEO Shailen Chande - CFO Conference Call Participants Sairam Srinivas - Cormark Securities Tal...
NorthWest Healthcare: Keep Your Eye On That Leverage
Acquisitions streak did not stop for NorthWest Healthcare. With almost a billion in properties bought in 2022, leverage and risks have moved up.
NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF) CEO Paul Dalla Lana on Q2 2022 Results - Earnings Call Transcript
NorthWest Healthcare Properties Real Estate Investment Trust (OTC:NWHUF) Q2 2022 Earnings Conference Call August 12, 2022 10:00 AM ET Company Participants Paul Dalla Lana - Chairman & Chief Executive Officer Shailen Chande - Chief Financial Officer Conference Call Participants Sairam...
NorthWest Healthcare: After Price Drop, This REIT Is Even More Attractive
Given a steep price fall in last month, I expect a double-digit total return this year. Four out of its five global markets are considered to be the topmost destinations for comfortable retirement, which will enhance the demand for medical...
Source: https://incomestatements.info
Category: Stock Reports